End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
27.5 TWD | +0.73% | -1.08% | -17.04% |
May. 15 | Adimmune Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 28 | Adimmune Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | 2.25B 69.36M | Sales 2023 | 1.79B 54.99M | Capitalization | 13.97B 430M |
---|---|---|---|---|---|
Net income 2022 | 291M 8.96M | Net income 2023 | -640M -19.72M | EV / Sales 2022 | 6.43 x |
Net cash position 2022 | 695M 21.41M | Net Debt 2023 | 673M 20.72M | EV / Sales 2023 | 8.2 x |
P/E ratio 2022 |
52.4
x | P/E ratio 2023 |
-21.8
x | Employees | 564 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 68.73% |
1 day | +0.73% | ||
1 week | -1.08% | ||
1 month | +0.73% | ||
3 months | -6.46% | ||
6 months | -22.97% | ||
Current year | -17.04% |
Managers | Title | Age | Since |
---|---|---|---|
Chung Cheng Liu
CEO | Chief Executive Officer | - | 19-06-19 |
Yin Teng Chang
DFI | Director of Finance/CFO | - | 20-12-31 |
Chi Hsien Chan
CHM | Chairman | - | 08-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Hsiao Po Hsu
BRD | Director/Board Member | - | 11-08-14 |
Chi Hsien Chan
CHM | Chairman | - | 08-06-30 |
Wei-Kuang Chi
BRD | Director/Board Member | - | 01-06-07 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 4 M€ | -4.41% | - | |
0.00% | 112 M€ | +4.61% | - | |
0.00% | 34 M€ | +3.86% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 27.5 | +0.73% | 702,782 |
24-05-30 | 27.3 | -0.91% | 413,792 |
24-05-29 | 27.55 | -0.72% | 430,463 |
24-05-28 | 27.75 | +1.28% | 622,804 |
24-05-27 | 27.4 | -1.44% | 839,531 |
End-of-day quote Taiwan S.E., May 30, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-17.04% | 356M | |
-2.29% | 89.87B | |
-3.95% | 37.57B | |
-13.07% | 32.75B | |
+63.05% | 26.47B | |
-22.14% | 14.25B | |
-7.96% | 12.99B | |
-9.33% | 11.93B | |
-46.33% | 10.84B | |
+5.77% | 9.11B |
- Stock Market
- Equities
- 4142 Stock